| abstract |
The invention proposed compounds capable of modulating the activity of histone demethylase (HDME) and which are suitable for the prevention and / or treatment of diseases in the pathogenesis of which dysregulation of the genome is involved, such as, for example, cancer. The invention also provides pharmaceutical compositions containing said compounds, and the use of said compounds as a medicine. The compounds have the formula (I) |